LP
RVNC

LMR Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

LMR Partners’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,000
Closed -$304K – 1721
2024
Q4 		$304K Buy
+100,000
New +$436K ﹤0.01% 902

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LMR Partners's RVNC Position: Q1 2025 in Review

LMR Partners sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 347,207 shares — an estimated $1.06M sold.

LMR Partners first reported a position in RVNC in Q3 2022 and held it in 3 quarters. The position peaked at $11.6M in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • LMR Partners reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 347,207 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $1.06M.
  • LMR Partners first reported a position in Revance Therapeutics, Inc. in Q3 2022 and held it in 3 quarters.
  • LMR Partners's Revance Therapeutics, Inc. position peaked at $11.6M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.